Table 1 Patient Characteristics (n = 30)
| Â | No. of patients (%) |
|---|---|
Age | Â |
Mean | 44.30 |
Range | 26-65 |
Menopausal Status | Â |
Premenopausal | 13 (43.33) |
Postmenopausal | 17 (56.66) |
Tumor size before NACT | Â |
<5 cms | 4 (13.33) |
5-8 cms | 17 (56.66) |
8-10 cms | 6 (20.00) |
>=10 cms | 3 (10.00) |
Tumor size after NACT | Â |
<5 cms | 19 (63.33) |
5-8 cms | 8 (26.66) |
8-10 cms | 3 (10.00) |
>=10 cms | 0 (0) |
Lymph node status before NACT | Â |
N1 | 9 (30.00) |
N2 | 19 (63.33) |
N3 | 2 (6.66) |
Lymph node status after NACT | Â |
N0 | 15 (50.00) |
N1 | 9 (30.00) |
N2 | 4 (13.33) |
N3 | 2 (6.66) |
Clinical response | Â |
Responders | 19 (63.33) |
Non-responders | 11 (36.66) |
Her-2neu Status | Â |
Positive | 11 (36.66) |
Negative | 19 (63.33) |
ER Status | Â |
Positive | 14 (46.66) |
Negative | 16 (53.33) |